Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/5191
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDei-Adomakoh, Yvonne-
dc.contributor.authorAkpalu, Josephine-
dc.contributor.authorYawson, Alfred E.-
dc.contributor.authorEkem5, Ivy-
dc.contributor.authorAtiase, Yacoba-
dc.date.accessioned2021-03-26T12:17:50Z-
dc.date.available2021-03-26T12:17:50Z-
dc.date.issued2019-06-
dc.identifier.urihttp://hdl.handle.net/123456789/5191-
dc.description.abstractBackground: Glucocorticoids (steroids) play a key role in the management of multiple medical conditions including haematological disorders. This study looked at the prevalence of steroid induced dysglycaemia in patients with haematological disorders receiving steroids as part of their treatment with the view of modifying its use and selection of patients where necessary.en_US
dc.language.isoenen_US
dc.subjectsteroidsen_US
dc.subjecthaematological disordersen_US
dc.subjectdysglycaemiaen_US
dc.subjectrisk factorsen_US
dc.titleSteroid-induced dysglycaemia in patients with haematological disorders a ten-year review in a tertiary hospital in Ghanaen_US
dc.typeArticleen_US
Appears in Collections:School of Medical Sciences

Files in This Item:
File Description SizeFormat 
Steroid-induced dysglycaemia in patients with haematological disorders a ten-year.pdf319.04 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.